Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patients

Marijke B. Coomans*, Martin J. B. Taphoorn, Neil K. Aaronson, Brigitta G. Baumert, Martin van den Bent, Andrew Bottomley, Alba A. Brandes, Olivier Chinot, Corneel Coens, Thierry Gorlia, Ulrich Herrlinger, Florence Keime-Guibert, Annika Malmstrom, Francesca Martinelli, Roger Stupp, Andrea Talacchi, Michael Weller, Wolfgang Wick, Jaap C. Reijneveld, Linda DirvenEORTC Quality Life Grp, EORTC Brain Tumor Group

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)668-675
Number of pages8
JournalNeuro-Oncology Practice
Volume7
Issue number6
DOIs
Publication statusPublished - Dec 2020

Keywords

  • brain tumor
  • patient-reported outcome
  • quality of life
  • questionnaire
  • BEVACIZUMAB
  • VALIDATION

Cite this